Gut microbes, the innate immune system and inflammatory bowel disease: location, location, location.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 17133076)

Published in Curr Opin Gastroenterol on January 01, 2007

Authors

Edgar C Boedeker

Articles citing this

Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol (2012) 1.01

Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol (2011) 0.79

Articles by these authors

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60

The QseC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci U S A (2006) 3.07

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis (2010) 2.62

Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One (2012) 1.82

Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol (2008) 1.28

Virulence inhibition by zinc in shiga-toxigenic Escherichia coli. Infect Immun (2011) 1.08

Effect of zinc in enteropathogenic Escherichia coli infection. Infect Immun (2007) 1.05

Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin. Infect Immun (2005) 0.97

Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli. Infect Immun (2013) 0.96

Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain. Vaccine (2005) 0.94

Use of a continuous-flow anaerobic culture to characterize enteric virulence gene expression. Infect Immun (2004) 0.86

The possible influence of LuxS in the in vivo virulence of rabbit enteropathogenic Escherichia coli. Vet Microbiol (2007) 0.85

Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli. Vaccine (2005) 0.84

Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation. Vet Immunol Immunopathol (2012) 0.82

Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium. PLoS One (2013) 0.82

Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3. Exp Cell Res (2009) 0.78

Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector. Microb Pathog (2009) 0.78

Helicobacter pylori infection: treatment. Curr Opin Gastroenterol (2002) 0.77

A directed intimin insertion mutant of a rabbit enteropathogenic Escherichia coli (REPEC) is attenuated, immunogenic and elicits serogroup specific protection. Vet Immunol Immunopathol (2012) 0.76

Correction: Identification of Candidate Adherent-Invasive E. coli Signature Transcripts by Genomic/Transcriptomic Analysis. PLoS One (2015) 0.75

Gastrointestinal infections. Curr Opin Gastroenterol (2003) 0.75

Gastrointestinal infections: an overview. Curr Opin Gastroenterol (2004) 0.75

Foodborne enteric infections. Curr Opin Gastroenterol (2003) 0.75